Short answer · Medically reviewed summary · Last updated: 2026-05-08
The primary medical billing code for Polymyalgia Rheumatica is M35.3 under the ICD-10-CM classification system. In the older ICD-9-CM coding system, Polymyalgia Rheumatica was classified under code 725. What is the clinical significance of these codes for Polymyalgia Rheumatica? Diagnostic coding for Polymyalgia Rheumatica is essential for ensuring patients receive appropriate insurance coverage for specialized care, such as rheumatology consultations and long-term corticosteroid therapy.
ICD10 code of Polymyalgia Rheumatica and ICD9 code
ICD-10 and ICD-9 codes for Polymyalgia Rheumatica, with classification details for clinicians, coders and patients.
The primary medical billing code for Polymyalgia Rheumatica is M35.3 under the ICD-10-CM classification system. In the older ICD-9-CM coding system, Polymyalgia Rheumatica was classified under code 725.
What is the clinical significance of these codes for Polymyalgia Rheumatica?
Diagnostic coding for Polymyalgia Rheumatica is essential for ensuring patients receive appropriate insurance coverage for specialized care, such as rheumatology consultations and long-term corticosteroid therapy. Accurate coding helps healthcare providers track the management of Polymyalgia Rheumatica, which typically presents as severe stiffness and aching in the shoulders, neck, and pelvic girdle, primarily in individuals over the age of 50.
How is Polymyalgia Rheumatica diagnosed?
There is no single definitive test for Polymyalgia Rheumatica; diagnosis relies on a combination of clinical assessment and laboratory markers. Physicians typically look for the following criteria to confirm a diagnosis:
- Age of onset 50 years or older.
- Bilateral shoulder or pelvic girdle pain and morning stiffness lasting longer than 45 minutes.
- Elevated inflammatory markers, specifically C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).
- Rapid, positive response to low-dose corticosteroid treatment (e.g., prednisone).
- Exclusion of other conditions like rheumatoid arthritis or giant cell arteritis.
Is Polymyalgia Rheumatica associated with other conditions?
Clinicians must remain vigilant because Polymyalgia Rheumatica is closely linked to giant cell arteritis (GCA), a serious inflammation of the blood vessels. Approximately 15% to 20% of patients diagnosed with Polymyalgia Rheumatica will eventually develop GCA. At DiseaseMaps.org, 52 members have shared their experiences, highlighting the importance of monitoring for vision changes or new headaches, which are red flags for GCA.
Next steps
- Consult a board-certified rheumatologist to confirm your diagnosis and establish a monitoring plan.
- Join the Polymyalgia Rheumatica community on DiseaseMaps.org to connect with others managing this condition.
- Keep a symptom diary to track morning stiffness and response to medication to share with your medical team.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS): Polymyalgia Rheumatica.
- NIH Genetic and Rare Diseases Information Center (GARD): Polymyalgia Rheumatica.
- ICD-10 Data: M35.3 Polymyalgia rheumatica.
- American College of Rheumatology: Polymyalgia Rheumatica Guidelines.
